Literature DB >> 9626866

Implementation and evaluation of a new pulse sequence for rapid acquisition of double inversion recovery images for simultaneous suppression of white matter and CSF.

B J Bedell1, P A Narayana.   

Abstract

We describe a fast double inversion recovery (DIR) imaging sequence that effectively attenuates signal from both white matter and cerebrospinal fluid (CSF). The pulse sequence uses a novel inversion/excitation scheme and fast spin-echo readout to maximize scan efficiency. The white matter/CSF suppressed images can be acquired from the entire brain in approximately 6 minutes. Evaluation of the fast DIR sequence on patients with multiple sclerosis (MS) demonstrates high lesion conspicuity.

Entities:  

Mesh:

Year:  1998        PMID: 9626866     DOI: 10.1002/jmri.1880080305

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  17 in total

1.  Improved identification of intracortical lesions in multiple sclerosis with phase-sensitive inversion recovery in combination with fast double inversion recovery MR imaging.

Authors:  F Nelson; A H Poonawalla; P Hou; F Huang; J S Wolinsky; P A Narayana
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-20       Impact factor: 3.825

2.  A comparative MRI study for white matter hyperintensities detection: 2D-FLAIR, FSE PD 2D, 3D-FLAIR and FLAIR MIP.

Authors:  Á Paniagua Bravo; J J Sánchez Hernández; L Ibáñez Sanz; I Alba de Cáceres; J L Crespo San José; B García-Castaño Gandariaga
Journal:  Br J Radiol       Date:  2014-02-03       Impact factor: 3.039

3.  Double inversion recovery brain imaging at 3T: diagnostic value in the detection of multiple sclerosis lesions.

Authors:  M P Wattjes; G G Lutterbey; J Gieseke; F Träber; L Klotz; S Schmidt; H H Schild
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

4.  The value of qualitative and quantitative assessment of lesion to cerebral cortex signal ratio on double inversion recovery sequence in the differentiation of demyelinating plaques from non-specific T2 hyperintensities.

Authors:  Salih Hamcan; Bilal Battal; Veysel Akgun; Oguzhan Oz; Yalcin Bozkurt; Serdar Tasdemir; Sebahattin Sari; Mustafa Tasar
Journal:  Eur Radiol       Date:  2016-04-23       Impact factor: 5.315

5.  Automated patient-specific optimization of three-dimensional double-inversion recovery magnetic resonance imaging.

Authors:  Refaat E Gabr; Xiaojun Sun; Amol S Pednekar; Ponnada A Narayana
Journal:  Magn Reson Med       Date:  2015-03-11       Impact factor: 4.668

Review 6.  High field MRI in the diagnosis of multiple sclerosis: high field-high yield?

Authors:  Mike P Wattjes; Frederik Barkhof
Journal:  Neuroradiology       Date:  2009-03-11       Impact factor: 2.804

7.  Caudate nuclei volume, diffusion tensor metrics, and T(2) relaxation in healthy adults and relapsing-remitting multiple sclerosis patients: implications for understanding gray matter degeneration.

Authors:  Khader M Hasan; Christopher Halphen; Arash Kamali; Flavia M Nelson; Jerry S Wolinsky; Ponnada A Narayana
Journal:  J Magn Reson Imaging       Date:  2009-01       Impact factor: 4.813

8.  Multi-contrast, isotropic, single-slab 3D MR imaging in multiple sclerosis.

Authors:  Bastiaan Moraal; Stefan D Roosendaal; Petra J W Pouwels; Hugo Vrenken; Ronald A van Schijndel; Dominik S Meier; Charles R G Guttmann; Jeroen J G Geurts; Frederik Barkhof
Journal:  Eur Radiol       Date:  2008-05-29       Impact factor: 5.315

9.  Double inversion recovery sequence of the cervical spinal cord in multiple sclerosis and related inflammatory diseases.

Authors:  I Riederer; D C Karampinos; M Settles; C Preibisch; J S Bauer; J F Kleine; M Mühlau; C Zimmer
Journal:  AJNR Am J Neuroradiol       Date:  2014-08-28       Impact factor: 3.825

10.  Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla.

Authors:  Birgit Simon; Stephan Schmidt; Carsten Lukas; Jürgen Gieseke; Frank Träber; Dirk L Knol; Winfried A Willinek; Jeroen J G Geurts; Hans H Schild; Frederik Barkhof; Mike P Wattjes
Journal:  Eur Radiol       Date:  2010-01-22       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.